During the past decade, Wellmont Medical Associates Oncology and Hematology-Johnson City conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 16 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 14 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wellmont Medical Associates Oncology and Hematology-Johnson City" #1 sponsor was "National Cancer Institute (NCI)" with 22 trials, followed by "Children's Oncology Group" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NSABP Foundation Inc" with 4 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wellmont Medical Associates Oncology and Hematology-Johnson City" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Wellmont Medical Associates Oncology and Hematology-Johnson City" are "Leukemia" (6 trials), "Ovarian Seromucinous Carcinoma" (4 trials), "Recurrent Fallopian Tube Carcinoma" (4 trials), "Recurrent Ovarian Carcinoma" (4 trials) and "Recurrent Primary Peritoneal Carcinoma" (4 trials). Many other conditions were trialed in "Wellmont Medical Associates Oncology and Hematology-Johnson City" in a lesser frequency.

Most popular intervention types in "Wellmont Medical Associates Oncology and Hematology-Johnson City" are "Drug" (44 trials), "Other" (28 trials), "Biological" (15 trials), "Procedure" (13 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Quality-of-Life Assessment" (11 trials), "cyclophosphamide" (8 trials), "Computed Tomography" (7 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Wellmont Medical Associates Oncology and Hematology-Johnson City" are 42 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Wellmont Medical Associates Oncology and Hematology-Johnson City". undefined are not yet recruiting, 4 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Wellmont Medical Associates Oncology and Hematology-Johnson City, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Wellmont Medical Associates Oncology and Hematology-Johnson City, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".